Papers
7
Total Citations
90
H-Index
5
About
Paul Sargos is a leading French urologic oncologist whose research has profoundly shaped the modern surgical management of prostate and kidney cancers. His work centers on the nationwide analysis of radical prostatectomy outcomes, particularly comparing open, laparoscopic, and robotic surgical approaches. Sargos’ landmark studies, including his 2021 analysis of over 9,600 patients, demonstrated the safety and feasibility of same-day-discharge robot-assisted radical prostatectomy (RARP), challenging traditional postoperative care paradigms. His five-year nationwide evaluation of the radical prostatectomy landscape provides critical insights into evolving treatment patterns and their impact on patient outcomes. With key papers accumulating over 28 citations, Sargos has established a robust evidence base for surgical decision-making. He has also made significant contributions to salvage prostatectomy after brachytherapy failure and to the management of kidney cancer, serving as a primary author of the French AFU Cancer Committee Guidelines (2024–2026). His systematic reviews and meta-analyses on anatomic factors influencing complications further underscore his commitment to improving surgical safety. Through his pioneering use of large-scale national data, Sargos continues to drive evidence-based innovation in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7